Rare diseases
Investigational molecules
Locations
Via Ponte Della Fabbrica 3 A, 35031 Abano Terme, Italy
Clinical research includes treatment approaches for BCG-unresponsive carcinoma in situ of the bladder with or without Ta-T1 papillary disease, reflecting interest in difficult-to-treat non-muscle-invasive urothelial carcinoma.
The sponsor’s activity in this area is centered on bladder-preserving oncology and local treatment options for resistant disease.
Fidia Farmaceutici S.p.A. runs clinical trials in conditions such as Peyronie's disease, Back pain, Major depression, Bladder cancer stage 0 with cancer in situ, among others.
Clinical trials run by this sponsor – those enrolling participants first.
ItalyItalyItaly
France
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
